Neuralink Corp. is an American neurotechnology company founded by Elon Musk that is developing implantable brain-computer interfaces (BCIs). Their goal is to create a generalized brain interface to restore autonomy to those with unmet medical needs and unlock human potential. The company has developed a fully implantable and cosmetically invisible brain-computer interface called the N1 Implant, which allows users to control a computer or mobile device wirelessly. The implant consists of biocompatible enclosure, battery, chips and electronics, threads for recording neural activity, and a surgical robot for precise insertion. Neuralink is also building an app that enables users to manipulate a keyboard and mouse using only their mind. The company is actively recruiting individuals with diverse engineering, scientific, and operations expertise.

Elon Musk

Max Hodak

Laura G Aguirre

Neuralink Corp.

age1 is focused on investing in and supporting founders developing therapeutics, tools, and technologies targeting aging and age-related disease, with the goal of extending healthy lifespan and preventing disease onset.

age1

Neuralink is a team of exceptionally talented people. We are creating the future of brain-machine interfaces: building devices now that will help people with paralysis and inventing new technologies that will expand our abilities, our community, and our world.

Our goal is to build a system with at least two orders of magnitude more communication channels (electrodes) than current clinically-approved devices. This system needs to be safe, it must have fully wireless communication through the skin, and it has to be ready for patients to take home and use on their own. Our device, called the Link, will be able to record from 1024 electrodes and is designed to meet these criteria.

Mirza Canada

Raison

Craft Ventures

Vy Capital

Gigafund

Valor Equity Partners

Vantage Legacy Capital

Founders Fund

Google Ventures

Blake Byers

Fred Ehrsam

Ken Howery

Robert Nelsen

Sam Altman

Roman Smolevskiy

Neuralink

We’re excited to announce that recruitment is open for our first-in-human clinical trial!

If you're interested in learning more about our clinical trial, check out our recent blog post below or download the study brochure.  

https://lnkd.in/g3bqpCBG 

https://lnkd.in/gw43kV8v

If you’re interested in helping bring this technology to the people who could benefit the most, consider joining us. Explore our open roles: www.neuralink.com/careers.

We’re happy to announce our $280M Series D round.  We’re extremely excited about this next chapter at Neuralink. 

If you’d like to help make the first human experience incredible and work on engineering challenges to restore vision and mobility, come join! https://lnkd.in/gMNC2st

We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!

This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people.

Recruitment is not yet open for our clinical trial. However, recruitment is open to exceptional people looking to further our mission: to create a generalized brain interface to restore autonomy to those with unmet medical needs today and unlock human potential tomorrow.

Come join us during this exciting time for our company!

We are committed to excellence in animal care, and take pride in our unwavering dedication to treating each and every animal with empathy, skill, and the utmost respect. The expertise and compassion demonstrated by Neuralink's animal care team is truly remarkable, setting a benchmark for the industry to follow. 
 #respect #empathy #team 

Metric
Company Name	Neuralink Corp.	age1
Symbol
MSH ID	COM:NEURALINK	COM:AGE1
Market	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services
Industry	Neurotechnology	Biotechnology
Country	US	US
Stage
Employee Count	443
Website	neuralink.com	age1.com
LinkedIn	neuralink
Founders

Metric
Market Cap	398.33M
Enterprise Value
Monthly Web Traffic	271.66K	1.07K
Web Traffic Growth	-0.07	-0.20
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:NEURALINK

Neuralink Corp.

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue